Invention Grant
- Patent Title: Quaternary ammonium salts as M3 antagonists
- Patent Title (中): 季铵盐作为M3拮抗剂
-
Application No.: US11721989Application Date: 2005-12-22
-
Publication No.: US08153669B2Publication Date: 2012-04-10
- Inventor: Neil John Press , Stephen Paul Collingwood
- Applicant: Neil John Press , Stephen Paul Collingwood
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Cozette M McAvoy
- Priority: GB0428418.8 20041224
- International Application: PCT/EP2005/013897 WO 20051222
- International Announcement: WO2006/066929 WO 20060629
- Main IPC: A61K31/42
- IPC: A61K31/42 ; C07D403/12
Abstract:
Compounds of formula (I), in salt or zwitterionic form, wherein J, L, M, R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Public/Granted literature
- US20090227590A1 QUATERNARY AMMONIUM SALTS AS M3 ANTAGONISTS Public/Granted day:2009-09-10
Information query
